ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,894.40
0.84%
S&P ASX All Technology
3,524.70
1.86%
Brent Oil
70.785
0.31%
US Dollar vs AUD
1.57913
0.50%
Bitcoin
86,301.91
-0.68%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Penumbra Inc (PEN) Share Price

Penumbra Inc

Penumbra Inc (PEN)

Peninsula Energy Ltd
Pennant International Group Plc
PBF Energy Inc
279.48
4.19
(1.52%)
Closed 20 March 7:00AM
Delayed by 15 minutes
279.48
0.00
(0.00%)
After Hours: 9:49AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
279.48
Bid
-
Offer
-
Volume
532,310
271.07 Day's Range 281.16
148.00 52 Week Range 310.00
Market Cap
10.764B
Previous Close
275.29
Open
276.07
Last Trade
63271
@
279.48
Last Trade Time
Financial Volume
US$ 147,659,270
VWAP
277.3934
Average Volume (3m)
466,474
Shares Outstanding
38,515,949
Dividend Yield
-
PE Ratio
769.35
Earnings Per Share (EPS)
0.36
Revenue
1.19B
Net Profit
14.01M

About Penumbra Inc

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Website
www.penumbrainc.com
Headquarters
Dover, Delaware, USA
Founded
-
Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was US$275.29. Over the last year, Penumbra shares have traded in a share price range of US$ 148.00 to US$ 310.00.

Penumbra currently has 38,515,949 shares in issue. The market capitalisation of Penumbra is US$10.60 billion. Penumbra has a price to earnings ratio (PE ratio) of 769.35.

Ask ADVFN Intelligence (AI)

PEN Latest News

More News

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
5 hours ago
PEN (1.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 March 2025
PEN (1.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
19 March 2025
PEN (1.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
08 March 2025
PEN (1.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
PEN (1.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
PEN (1.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
PEN (1.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
PEN (1.52%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
06 March 2025
PEN (1.52%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
06 March 2025
PEN (1.52%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
113.475.06371940904266.01279.89256.54346805270.33064695CS
4-16.62-5.61296859169296.1310254.5506457284.13411839CS
1240.6917.0400770552238.79310222.59466474269.85546349CS
2679.1939.537670378200.29310185.13399114247.25990073CS
5244.5618.9681593734234.92310148401269220.05829066CS
15666.431.1620048808213.08348.67114.865375229223.17992504CS
260138.3398.0021253985141.15348.67114.865354100224.58963117CS

PEN - Frequently Asked Questions (FAQ)

What is the current Penumbra share price?
The current share price of Penumbra is US$ 279.48
How many Penumbra shares are in issue?
Penumbra has 38,515,949 shares in issue
What is the market cap of Penumbra?
The market capitalisation of Penumbra is USD 10.6B
What is the 1 year trading range for Penumbra share price?
Penumbra has traded in the range of US$ 148.00 to US$ 310.00 during the past year
What is the PE ratio of Penumbra?
The price to earnings ratio of Penumbra is 769.35
What is the cash to sales ratio of Penumbra?
The cash to sales ratio of Penumbra is 9.02
What is the reporting currency for Penumbra?
Penumbra reports financial results in USD
What is the latest annual turnover for Penumbra?
The latest annual turnover of Penumbra is USD 1.19B
What is the latest annual profit for Penumbra?
The latest annual profit of Penumbra is USD 14.01M
What is the registered address of Penumbra?
The registered address for Penumbra is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
What is the Penumbra website address?
The website address for Penumbra is www.penumbrainc.com
Which industry sector does Penumbra operate in?
Penumbra operates in the SURGICAL,MED INSTR,APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BGSFBGSF Inc
US$ 4.21
(18.59%)
286.84k
SIGSignet Jewelers Ltd
US$ 56.6958
(17.38%)
4.99M
SPCEVirgin Galactic Holdings Inc
US$ 4.33
(14.55%)
7.56M
STEMStem Inc
US$ 0.45815
(13.15%)
3.7M
SMRNuScale Power Corporation
US$ 18.53
(11.76%)
8.08M
IHiHuman Inc
US$ 2.68
(-15.72%)
187.87k
TKCTurkcell lletism Hizmetleri AS
US$ 6.50
(-13.91%)
2.4M
TISITeam Inc
US$ 14.25
(-13.64%)
34.59k
CANGCango Inc
US$ 4.17
(-10.52%)
576.22k
SESSES AI Corporation
US$ 0.55
(-10.47%)
24.29M
FFord Motor Company
US$ 10.17
(2.21%)
124.7M
QBTSD Wave Quantum Inc
US$ 10.585
(-1.99%)
90.27M
VALEVale SA
US$ 10.195
(0.15%)
47.71M
RIGTransocean Ltd
US$ 3.14
(-1.88%)
47.38M
NUNu Holdings Ltd
US$ 11.955
(3.96%)
47.19M

PEN Discussion

View Posts
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ALL NEWS IS GOOD? ... $PEN



CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
👍️0
davidsson10 davidsson10 4 years ago
https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
👍️0
@LaughinPaulRyan @LaughinPaulRyan 4 years ago
... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
👍️0
TREND1 TREND1 10 years ago
IPO INFO

http://www.marketwatch.com/tools/ipo-calendar
👍️0
TREND1 TREND1 10 years ago
IPO NOW HAS SYMBOL
Penumbra PEN
👍️0
TREND1 TREND1 10 years ago
IPO should be out soon.
no symbol yet.
👍️0

Your Recent History

NYSE
PEN
Penumbra
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads